Anti-cancer medicine composition containing antimetabolite
A technology of anti-cancer drugs and compositions, which is applied in the direction of drug combinations, anti-tumor drugs, active ingredients of heterocyclic compounds, etc., and can solve problems such as difficulty in forming effective drug concentrations
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0049] Put 90 mg of PLGA (copolymer of glycolic acid and glycolic acid) with a molecular weight of 10,000 into a container, add 100 ml of dichloromethane, dissolve and mix, add 10 mg of gemcitabine, re-shake, and then vacuum-dry to remove the organic solvent. The dried solid composition is shaped immediately, subpackaged and sterilized by radiation to obtain an anticancer drug composition containing 10% by weight of gemcitabine. The drug release time of the anticancer drug composition in the physiological saline in vitro is 15-20 days, and the drug release time in the mouse subcutaneous is about 30-40 days.
Embodiment 2
[0050] Embodiment 2. As described in embodiment 1, the difference is that anti-metabolite drugs are:
[0051] (a) 1-50% deoxyfluorouridine, 5-deoxyfluorouridine, fluorouracil, propylthiouracil, butylfluorouracil, bisfluoropyrimidine, 5-fluoropyrimidinol, sodium sulfcaptopurine, thiocarbamide Purine, 6-mercaptopurine, 6-aminopurine hydrochloride, glycine thiopurine, thioguanine, carcinol, hydrazine sulfate, viconol, seroquinone, fencolonine, isopyrone, inhibitor clodronate, clodronate disodium, cycloleucine, dizacitrin, mesinate dichacitrin, berquiqual, oxypurinol, amallide, brombamic acid (sodium ), Bailididine, bromouridine, hexylfluramide, 10-ethyldeazhotrexate, flumethotrexate, dioxetrexate, 5,10-dideazatetrahydrofolate, Methotrexate, butylmercaptopurine, diketamide, cystazine guanidine, carmofur, uracil tegafur, pentene indole, thiorasin, Youfudine, metoxyberine, formyl Sarcoma, amino(yl)pterin, aminopterin sodium, 8-azaguanine, dimethylamine adenosine, (nitro)azathiopri...
Embodiment 3
[0057] Put 80 mg of pharmaceutical excipient ethylene vinyl acetate copolymer (EVAc) into a container, add 100 ml of dichloromethane to dissolve and mix well, add 20 mg of raltitrexed, re-shake, and then vacuum-dry to remove the organic solvent. The dried solid composition is shaped immediately, subpackaged and sterilized by radiation to obtain an anticancer drug composition containing 20% by weight of raltitrexed. The drug release time of the anticancer drug composition in the physiological saline in vitro is 14-24 days, and the drug release time in the mouse subcutaneous is about 20-35 days.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com